Adjuvant Lipoic acid Injection in Sepsis treatment in China (ALIS study): protocol for a randomised, single-blind, placebo-controlled trial

Adjuvant Lipoic acid Injection in Sepsis treatment in China (ALIS study): protocol for a randomised, single-blind, placebo-controlled trial

Introduction Sepsis is a life-threatening immune disorder resulting from an dysregulated host response to infection. Adjuvant therapy is a valuable complement to sepsis treatment. Lipoic acid has shown potential in attenuating sepsis-induced immune dysfunction and organ injury in vivo and in vitro s...

Full description

Bibliographic Details
Main Authors: Linhui Hu, Chunbo Chen, Xinjuan Zhou, Jinbo Huang, Yuemei He, Quanzhong Wu, Xiangwei Huang, Kunyong Wu, Guangwen Wang, Sinian Li, Xiangyin Chen
Format: Article
Language:English
Published: BMJ Publishing Group 2023-07-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/13/7/e072897.full

Internet

https://bmjopen.bmj.com/content/13/7/e072897.full

Similar Items